dimecres, 12 de novembre del 2014

Report: Actavis may buy Allergan for at least $60 billion

Report: Actavis may buy Allergan for at least $60 billion

Actavis, Pershing Square Capital Management, Valeant Pharmaceuticals, Allergan Inc.

News Well, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beat

read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ucuhvH
Publicat per a
Etiquetes de comentaris: ,

Cap comentari:

Publica un comentari a l'entrada

Subscriure's a: Comentaris del missatge (Atom)